BioCentury | May 21, 2012
Company News
Neurotune, ALS Therapy Development Institute (ALS TDI) deal
...ALS TDI said it will evaluate the efficacy of Neurotune's TDI-165 in a preclinical model of...
...ALS). TDI-165 is a biologic targeted at stabilizing the neuromuscular junction. Details were not disclosed. Neurotune AG...
...ALS). TDI-165 is a biologic targeted at stabilizing the neuromuscular junction. Details were not disclosed. Neurotune AG...